Copper(II)-bis(thiosemicarbazonato) complexes as anti-chlamydial agents.
Pathog Dis
; 75(7)2017 09 29.
Article
en En
| MEDLINE
| ID: mdl-28830076
Lipophilic copper (Cu)-containing complexes have shown promising antibacterial activity against a range of bacterial pathogens. To examine the susceptibility of the intracellular human pathogen Chlamydia trachomatis to copper complexes containing bis(thiosemicarbazone) ligands [Cu(btsc)], we tested the in vitro effect of CuII-diacetyl- and CuII-glyoxal-bis[N(4)-methylthiosemicarbazonato] (Cu(atsm) and Cu(gtsm), respectively) on C. trachomatis. Cu(atsm) and to a greater extent, Cu(gtsm), prevented the formation of infectious chlamydial progeny. Impacts on host cell viability and respiration were also observed in addition to the Chlamydia impacts. This work suggests that copper-based complexes may represent a new lead approach for future development of new therapeutics against chlamydial infections, although host cell impacts need to be fully explored.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Tiosemicarbazonas
/
Chlamydia trachomatis
/
Cobre
/
Complejos de Coordinación
/
Antibacterianos
Límite:
Humans
Idioma:
En
Revista:
Pathog Dis
Año:
2017
Tipo del documento:
Article
País de afiliación:
Australia
Pais de publicación:
Estados Unidos